Zeping Han

1.4k total citations · 1 hit paper
47 papers, 1.0k citations indexed

About

Zeping Han is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Zeping Han has authored 47 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 29 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Zeping Han's work include Cancer-related molecular mechanisms research (17 papers), Circular RNAs in diseases (17 papers) and MicroRNA in disease regulation (10 papers). Zeping Han is often cited by papers focused on Cancer-related molecular mechanisms research (17 papers), Circular RNAs in diseases (17 papers) and MicroRNA in disease regulation (10 papers). Zeping Han collaborates with scholars based in China, United States and Australia. Zeping Han's co-authors include Yuguang Li, Jinhua He, Zhonghui Guo, Jiabin Zhou, Mingrong Cao, Bowen Shu, Zhang Wang, Xiaoming Zhou, Miaomiao Ye and Lei Liu and has published in prestigious journals such as ACS Nano, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Zeping Han

42 papers receiving 1.0k citations

Hit Papers

An Ultralocalized Cas13a Assay Enables Universal and Nucl... 2020 2026 2022 2024 2020 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zeping Han China 17 804 520 160 78 62 47 1.0k
Joanna Kovalski United States 10 634 0.8× 289 0.6× 130 0.8× 64 0.8× 37 0.6× 13 961
Mohammed H. Rashed Egypt 13 978 1.2× 711 1.4× 67 0.4× 87 1.1× 73 1.2× 23 1.2k
Xing Zhao China 14 671 0.8× 523 1.0× 56 0.3× 42 0.5× 45 0.7× 55 859
José E. Guimarães Portugal 13 615 0.8× 280 0.5× 44 0.3× 162 2.1× 35 0.6× 26 934
Hanchu Xiong China 17 746 0.9× 589 1.1× 40 0.3× 148 1.9× 136 2.2× 35 1.1k
Marzia Pucci Italy 13 619 0.8× 414 0.8× 64 0.4× 125 1.6× 61 1.0× 19 805
Hanzi Xu China 20 948 1.2× 804 1.5× 39 0.2× 91 1.2× 74 1.2× 42 1.2k
Chengheng Liao United States 18 550 0.7× 277 0.5× 123 0.8× 143 1.8× 100 1.6× 24 874

Countries citing papers authored by Zeping Han

Since Specialization
Citations

This map shows the geographic impact of Zeping Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeping Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeping Han more than expected).

Fields of papers citing papers by Zeping Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zeping Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeping Han. The network helps show where Zeping Han may publish in the future.

Co-authorship network of co-authors of Zeping Han

This figure shows the co-authorship network connecting the top 25 collaborators of Zeping Han. A scholar is included among the top collaborators of Zeping Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zeping Han. Zeping Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Ying, et al.. (2025). Post-translational modifications of protein and lung cancer. Frontiers in Oncology. 15. 1667200–1667200.
2.
Gao, Xiangyu, Min Xu, Hao Xiao, et al.. (2025). Tumor-associated neutrophils: a complex role in cancer. Clinical Immunology. 280. 110558–110558. 1 indexed citations
3.
Han, Zeping, et al.. (2024). Targeted metabolomics combined with machine learning to identify and validate new biomarkers for early SLE diagnosis and disease activity. Clinical Immunology. 264. 110235–110235. 3 indexed citations
4.
Zhao, Ying, Wenfeng Luo, Xiaoyu Song, et al.. (2024). PLA inhibits TNF-α-induced PANoptosis of prostate cancer cells through metabolic reprogramming. The International Journal of Biochemistry & Cell Biology. 169. 106554–106554. 9 indexed citations
5.
Song, Xiaoyu, et al.. (2024). A Targeted Proteomics Approach Reveals a Serum Protein Signature as a Diagnostic Biomarker for Colorectal Cancer. Journal of Inflammation Research. Volume 17. 10755–10768. 1 indexed citations
6.
Cheng, Lulu, et al.. (2024). Identification and validation of a novel glycolysis-related ceRNA network for sepsis-induced cardiomyopathy. Frontiers in Medicine. 11. 1343281–1343281. 3 indexed citations
7.
Han, Zeping, Wenfeng Luo, Jian Shen, et al.. (2023). Serum organic acid metabolites can be used as potential biomarkers to identify prostatitis, benign prostatic hyperplasia, and prostate cancer. Frontiers in Immunology. 13. 998447–998447. 16 indexed citations
8.
Cheng, Lulu, Jie Feng, Zeping Han, et al.. (2023). Molecular mechanism of Danshenol C in reversing peritoneal fibrosis: novel network pharmacological analysis and biological validation. BMC Complementary Medicine and Therapies. 23(1). 361–361. 3 indexed citations
9.
He, Jinhua, Jian Shen, Wenfeng Luo, et al.. (2022). Research progress on application of single-cell TCR/BCR sequencing technology to the tumor immune microenvironment, autoimmune diseases, and infectious diseases. Frontiers in Immunology. 13. 969808–969808. 15 indexed citations
10.
Han, Zeping, et al.. (2022). Circular RNAs and Their Role in Exosomes. Frontiers in Oncology. 12. 848341–848341. 39 indexed citations
11.
He, Jinhua, et al.. (2021). The miR-203a Regulatory Network Affects the Proliferation of Chronic Myeloid Leukemia K562 Cells. Frontiers in Cell and Developmental Biology. 9. 616711–616711. 5 indexed citations
12.
Han, Zeping, et al.. (2021). Investigation and analysis on the application of peripheral blood specimens for routine blood testing by laboratory physicians. Annals of Palliative Medicine. 10(9). 9516–9522. 7 indexed citations
13.
Li, Guangchao, Qing Zhang, Zeping Han, et al.. (2021). IL-7 and CCR2b Co-Expression-Mediated Enhanced CAR-T Survival and Infiltration in Solid Tumors. Frontiers in Oncology. 11. 734593–734593. 21 indexed citations
14.
He, Jinhua, Feifeng Wu, Zeping Han, et al.. (2021). Biomarkers (mRNAs and Non-Coding RNAs) for the Diagnosis and Prognosis of Colorectal Cancer – From the Body Fluid to Tissue Level. Frontiers in Oncology. 11. 632834–632834. 30 indexed citations
15.
Li, Yuguang, Zeping Han, Jiabin Zhou, et al.. (2018). The CircRNA-ACAP2/Hsa-miR-21-5p/ Tiam1 Regulatory Feedback Circuit Affects the Proliferation, Migration, and Invasion of Colon Cancer SW480 Cells. Cellular Physiology and Biochemistry. 49(4). 1539–1550. 105 indexed citations
16.
Yang, Qingyuan, Wanrun Lin, Zhiwei Liu, et al.. (2018). RAP80 is an independent prognosis biomarker for the outcome of patients with esophageal squamous cell carcinoma. Cell Death and Disease. 9(2). 146–146. 17 indexed citations
17.
He, Jinhua, et al.. (2017). Overexpression of Long Non‐Coding RNA MEG3 Inhibits Proliferation of Hepatocellular Carcinoma Huh7 Cells via Negative Modulation of miRNA‐664. Journal of Cellular Biochemistry. 118(11). 3713–3721. 81 indexed citations
18.
He, Jinhua, Baoxia Li, Zeping Han, et al.. (2016). Snail-activated long non-coding RNA PCA3 up-regulates PRKD3 expression by miR-1261 sponging, thereby promotes invasion and migration of prostate cancer cells. Tumor Biology. 37(12). 16163–16176. 41 indexed citations
19.
Zhen, Ni, Qingyuan Yang, Kangdi Zheng, et al.. (2016). MiroRNA-127-3p targets XRCC3 to enhance the chemosensitivity of esophageal cancer cells to a novel phenanthroline-dione derivative. The International Journal of Biochemistry & Cell Biology. 79. 158–167. 11 indexed citations
20.
Wang, Li, Jinhua He, & Zeping Han. (2014). Characteristics of PVT1 and Its Roles in Diseases. Chinese Medical Sciences Journal. 29(4). 236–238. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026